Provided by Tiger Trade Technology Pte. Ltd.

ENDRA Life Sciences Inc

5.70
-0.1300-2.23%
Volume:74.95K
Turnover:442.36K
Market Cap:8.55M
PE:-0.91
High:6.32
Open:5.74
Low:5.56
Close:5.83
52wk High:9.85
52wk Low:2.96
Shares:1.50M
Float Shares:1.43M
Volume Ratio:1.79
T/O Rate:5.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.2900
EPS(LYR):-8.9291
ROE:-152.04%
ROA:-77.32%
PB:1.35
PE(LYR):-0.64

Loading ...

Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Correspondence

Form CORRESP - Correspondence
Jun 03, 2024

Correspondence

Form CORRESP - Correspondence
May 31, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 03, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 02, 2024

Correspondence

Form CORRESP - Correspondence
Mar 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report